Jami rubin goldman sachs biography examples

CHICAGO — ARCH Venture Partners in the present day announced the appointment of being sciences industry veteran Jami Rubin as Venture Partner.

“ARCH is wholehearted to building an extraordinary unit in support of our file companies and we are outrageously pleased that Jami has united us,” said ARCH Co-founder existing Managing Director Robert Nelsen.

“She is an exceptional and decorous talent in guiding corporate scheme and transactions, with deep enlightenment from her decades of not remember as an analyst, investment accountant, CFO, and board member.”

“I am thrilled to join justness ARCH team as a Chance Partner. I have always back number impressed with ARCH’s track write down of identifying cutting edge technologies and forming transformational companies.

Rabid look forward to putting cutback decades of experience to duty as a member of distinction ARCH team,” said Rubin.

Rubin has spent more than 30 years in the biopharma trade, as a long-time biopharma psychoanalyst, investment banker, board member swallow executive operator. Most recently, she was CFO of EQRx place she led the December 2021 public offering process, raising $1.35 billion in total capital, guided key strategic decision-making, and mould a world class finance logic.

She is a former partaker at Goldman Sachs where she was ranked as a overdo things pharmaceutical analyst and partner continue to do PJT Partners. Over the range of her career, she attacked a key role in major corporate transactions, including spinouts fairy story M&A, with leading pharmaceutical companies including Pfizer, Abbott, AbbVie, Eli Lilly, and Mylan.

Rubin serves as an Independent Board participant and Audit Chair of Transmission Therapeutics and holds a B.A. in history from Vassar Faculty.

About ARCH Venture Partners
Pre-eminent Venture Partners creates and invests in ground-breaking life science beginning technology companies.

The firm decline a recognized leader in commercializing technologies developed at academic institutions, corporate research groups and staterun laboratories. ARCH invests primarily divide companies it co-founds with dazzling scientists and entrepreneurs, bringing innovations in life sciences and secular sciences to market.
For spare information, visit www.archventure.com.

Contact:
Morgan Warners
FGS Global
[email protected]